Innovative point-of-care molecular diagnostic test for COVID-19 in India.
作者信息
Gupta Nivedita, Rana Salaj, Singh Harpreet
机构信息
Indian Council of Medical Research, New Delhi, 110029, India.
出版信息
Lancet Microbe. 2020 Nov;1(7):e277. doi: 10.1016/S2666-5247(20)30164-6. Epub 2020 Nov 4.
Abstract
摘要
相似文献
1
Innovative point-of-care molecular diagnostic test for COVID-19 in India.
Lancet Microbe. 2020 Nov;1(7):e277. doi: 10.1016/S2666-5247(20)30164-6. Epub 2020 Nov 4.
2
Rapid diagnostics for SARS-CoV-2 virus: point-of-care testing and lessons learned during the pandemic.
Bioanalysis. 2021 Aug;13(15):1165-1167. doi: 10.4155/bio-2021-0100. Epub 2021 Jul 21.
3
Multi-site point of care assessment of Abbott ID NOW rapid molecular test for SARS-CoV-2 in a low-prevalence setting.
Pathology. 2021 Dec;53(7):912-914. doi: 10.1016/j.pathol.2021.07.002. Epub 2021 Sep 4.
4
Molecular Diagnostic Tools for the Detection of SARS-CoV-2.
Int Rev Immunol. 2021;40(1-2):143-156. doi: 10.1080/08830185.2020.1871477. Epub 2021 Jan 13.
5
The rise of point-of-care genetics: how the SARS-CoV-2 pandemic will accelerate adoption of genetic testing in the acute setting.
Eur J Hum Genet. 2021 Jun;29(6):891-893. doi: 10.1038/s41431-021-00816-x. Epub 2021 Feb 15.
6
Comparison of abbott ID NOW COVID-19 rapid molecular assay to cepheid xpert xpress SARS-CoV-2 assay in dry nasal swabs.
Diagn Microbiol Infect Dis. 2021 Apr;99(4):115208. doi: 10.1016/j.diagmicrobio.2020.115208. Epub 2020 Sep 16.
7
Point-of-Care SARS-CoV-2 Variant Diagnostic in Development.
JAMA. 2021 Sep 14;326(10):901. doi: 10.1001/jama.2021.15116.
8
Clinical Performance of the Point-of-Care cobas Liat for Detection of SARS-CoV-2 in 20 Minutes: a Multicenter Study.
J Clin Microbiol. 2021 Jan 21;59(2). doi: 10.1128/JCM.02811-20.
9
Fast, Reliable, and Simple Point-of-Care-like Adaptation of RT-qPCR for the Detection of SARS-CoV-2 for Use in Hospital Emergency Departments.
Viruses. 2021 Dec 2;13(12):2413. doi: 10.3390/v13122413.
10
Evaluation of conventional and point-of-care real-time RT-PCR tests for the detection of SARS-CoV-2 through a pooled testing strategy.
J Clin Lab Anal. 2022 Jun;36(6):e24491. doi: 10.1002/jcla.24491. Epub 2022 May 9.
引用本文的文献
1
'CoviSwift: A point-of-care RT-PCR device for SARS-CoV-2 and its variant detection.
J Virol Methods. 2023 May;315:114714. doi: 10.1016/j.jviromet.2023.114714. Epub 2023 Mar 18.
2
Development of a rapid and ultra-sensitive RNA:DNA hybrid immunocapture based biosensor for visual detection of SARS-CoV-2 RNA.
PNAS Nexus. 2023 Feb 1;2(3):pgad031. doi: 10.1093/pnasnexus/pgad031. eCollection 2023 Mar.
3
A Rare Case of Sternoclavicular Tuberculosis Diagnosed Using Microchip-Based Polymerase Chain Reaction in a Diabetic Female.
Cureus. 2021 Oct 17;13(10):e18845. doi: 10.7759/cureus.18845. eCollection 2021 Oct.
4
Assessing a chip based rapid RTPCR test for SARS CoV-2 detection (TrueNat assay): A diagnostic accuracy study.
PLoS One. 2021 Oct 13;16(10):e0257834. doi: 10.1371/journal.pone.0257834. eCollection 2021.
5
Point-of-Care PCR Assays for COVID-19 Detection.
Biosensors (Basel). 2021 May 1;11(5):141. doi: 10.3390/bios11050141.
6
Review of Current COVID-19 Diagnostics and Opportunities for Further Development.
Front Med (Lausanne). 2021 May 7;8:615099. doi: 10.3389/fmed.2021.615099. eCollection 2021.
本文引用的文献
1
Performance evaluation of Truenat™ Beta CoV & Truenat™ SARS-CoV-2 point-of-care assays for coronavirus disease 2019.
Indian J Med Res. 2021;153(1 & 2):144-150. doi: 10.4103/ijmr.IJMR_2363_20.
2
Assessing a novel, lab-free, point-of-care test for SARS-CoV-2 (CovidNudge): a diagnostic accuracy study.
Lancet Microbe. 2020 Nov;1(7):e300-e307. doi: 10.1016/S2666-5247(20)30121-X. Epub 2020 Sep 17.
Zotero 插件